Theravance Biopharma (TBPH) Shareholder's Equity (2013 - 2026)
Theravance Biopharma (TBPH) Shareholder's Equity (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
290.59 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
290.59 Mn |
| Dec 31, 2025 |
296.72 Mn |
| Sep 30, 2025 |
232.68 Mn |
| Jun 30, 2025 |
224.85 Mn |
| Mar 31, 2025 |
165.98 Mn |
| Dec 31, 2024 |
175.55 Mn |
| Sep 30, 2024 |
185.65 Mn |
| Jun 30, 2024 |
193.69 Mn |
| Mar 31, 2024 |
204.87 Mn |
| Dec 31, 2023 |
213.00 Mn |
| Sep 30, 2023 |
246.13 Mn |
| Jun 30, 2023 |
280.16 Mn |
| Mar 31, 2023 |
370.56 Mn |
| Dec 31, 2022 |
441.80 Mn |
| Sep 30, 2022 |
480.58 Mn |
| Jun 30, 2022 |
-349.81 Mn |
| Mar 31, 2022 |
-351.45 Mn |
| Dec 31, 2021 |
-338.57 Mn |
| Sep 30, 2021 |
-323.59 Mn |
| Jun 30, 2021 |
-300.37 Mn |
